fvh1
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2012 (NCT01587131)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza virusImmunity, active
Influenza virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fvh1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01587131 | Phase 1 | Jun 1, 2012 | Inovio Pharmaceuticals, National Microbiology Laboratory, Canada, University of Manitoba |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals | For profit | 1 | 0 | 1 | 2012 |
| National Microbiology Laboratory, Canada | Government | 1 | 0 | 1 | 2012 |
| University of Manitoba | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1